Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD

INTRODUCTION: It is inaccurate to assess blood glucose with glycated hemoglobin (HbA1c) in patients with diabetes and chronic kidney disease (CKD), and whether glycated albumin (GA) is better than HbA1c in these patients remains unclear. METHODS: We searched PubMed, Embase, Web of Science, Scopus, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Ting, Liu, Xin, Xu, Gaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976809/
https://www.ncbi.nlm.nih.gov/pubmed/29854962
http://dx.doi.org/10.1016/j.ekir.2017.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976809/
https://www.ncbi.nlm.nih.gov/pubmed/29854962
http://dx.doi.org/10.1016/j.ekir.2017.11.009

Ejemplares similares